Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000899243-21-036139

Chief Business Officer sold 55,000 shares at an average $20.54 ($1,129,923)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Robb Gary Charles Chief Business Officer 2021-09-13 Sale −6,341 $20.89 $132,445 136,507 D
Robb Gary Charles Chief Business Officer 2021-09-14 Sale −806 $20.76 $16,736 135,701 D
Robb Gary Charles Chief Business Officer 2021-09-15 Sale −47,853 $20.49 $980,742 87,848 D
Open-market sales · 55,000 sh · avg $20.54 · $1,129,923
Loading xslF345X03/doc4.xml…